Overview

Microplasmin Intravitreal Administration in Participants With Uveitic Macular Edema

Status:
Terminated
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the safety and efficacy of microplasmin as a treatment for uveitic macular edema.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
National Institutes of Health Clinical Center (CC)
Collaborator:
National Eye Institute (NEI)
Treatments:
Fibrinolysin
Plasminogen